Temporary conjunctival flap for high risk fungal keratitis
Not Applicable
- Conditions
- Eye Diseasesfungal keratitis
- Registration Number
- PACTR202311888706058
- Lead Sponsor
- zagazig university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
1-patients with fungal keratitis and positive direct smear
2-high risk of perforation Deep
a-involving post 1/3 of corneal stroma )
b-the size of ulcer more than 6 mm
c- presence of hypoyon
Exclusion Criteria
1-Superficial small corneal ulcer
2-Previous conjunctival flap or amniotic membrane graft
3-perforated ulcer
4-Mixed infections
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of temporary conjunctival flap in treating fungal keratitis?
How does temporary conjunctival flap compare to antifungal medications in high-risk fungal keratitis treatment outcomes?
Are there specific biomarkers that predict successful patient selection for temporary conjunctival flap therapy in fungal keratitis?
What are the potential adverse events associated with temporary conjunctival flap procedures for fungal keratitis and their management strategies?
What combination therapies or alternative surgical approaches are being explored alongside temporary conjunctival flap for fungal keratitis treatment?